SB
Sumit Raosaheb Birangal
Manipal Academy of Higher Education, Suven Life Sciences Limited, Manipal College of Pharmaceutical Sciences, KCTS Ravindra Gambhirrao Sapkal College Of Pharmacy
Employment
-
Manipal Academy of Higher Education Research Scholar2019 - Present
-
Suven Life Sciences Limited Senior Chemist2016 - 2019
Education
-
Manipal College of Pharmaceutical Sciences PhD2019 - Present
-
Manipal College of Pharmaceutical Sciences M. Pharmacy2014 - 2016
-
KCTS Ravindra Gambhirrao Sapkal College Of Pharmacy B. Pharmacy2009 - 2014
Projects & Funding
Projects & funding information is unavailable.
Publications (40)
- Optimizing Cardiovascular Treatment in Non-Small Cell Lung Cancer: A Comprehensive Computational Approach for Assessment of Drug-Drug Interactions Between Tyrosine Kinase Inhibitors and Cardiovascular Drugs [version 2; peer review: 2 approved, 1 approved… Save
- Design, synthesis, and preclinical evaluation of novel 1-benzylpiperidine derivatives as multitarget agents against Alzheimer's disease Save
- Natamycin Cyclodextrin Supramolecular Complex Loaded Dissolvable Lenses for the Effective Management of Fungal Keratitis Save
- Drug-silica-cellulose ternary matrix for the oral delivery of Cyclosporine A: in vitro and in vivo evaluation Save
- Developing novel indoles as antitubercular agents and simulated annealing-based analysis of their binding with MmpL3 (Vol 17, Pg 19, 2024) Save
- Computational design, synthesis, in vitro and in vivo evaluation of a 3,4-methylenedioxyphenol (sesamol) derivative as an NRF2/HO-1 pathway activator for protection against drug-induced liver injury Save
- Uncovering the Anti-Herpetic Activity of Anionic Peptides Derived From the Cytoplasmic Domain of Nectin-1 Save
- MOLECULAR TARGETS AS POTENTIAL PI3Kα INHIBITORS AGAINST AGGRESSIVE METASTATIC DUCTAL AND LOBULAR CARCINOMA Save
- A computational study to identify Sesamol derivatives as NRF2 activator for protection against drug-induced liver injury (DILI) Save
- An in-silico approach for the identification of natural compounds as potential BACE1 inhibitors for the treatment of Alzheimer disease Save